Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilbert Zwart

Showing results (61-70 of 178) with videos related to

Pageof 18
Sort By:
Oncotarget|September 15, 2017
Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapyWillemijne A M E Schrijver, Karianne Schuurman, Annelot van Rossum, et al.
Oncotarget|April 21, 2016
mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinomaSuzan Stelloo, Joyce Sanders, Ekaterina Nevedomskaya, et al.
Genes & Development|December 28, 2019
TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer developmentLisette M Cornelissen, Anne Paulien Drenth, Eline van der Burg, et al.
JCI Insight|January 25, 2019
Frequent clonal relations between metastases and non-index prostate cancer lesionsJeroen Kneppers, Oscar Krijgsman, Monique Melis, et al.
Endocrine-Related Cancer|December 6, 2019
Androgen modulation of XBP1 is functionally driving part of the AR transcriptional programSuzan Stelloo, Simon Linder, Ekaterina Nevedomskaya, et al.
Cancer Research|August 23, 2014
Complex formation and function of estrogen receptor α in transcription requires RIP140Meritxell Rosell, Ekaterina Nevedomskaya, Suzan Stelloo, et al.
Scientific Reports|July 2, 2021
A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancerSander A L Palit, Jeroen van Dorp, Daniel Vis, et al.
Development (Cambridge, England)|February 14, 2013
The transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signalsJaya Nautiyal, Jennifer H Steel, Meritxell Rosell Mane, et al.
Nature Reviews. Urology|December 17, 2020
Genomic and phenotypic heterogeneity in prostate cancerMichael C Haffner, Wilbert Zwart, Martine P Roudier, et al.
Iscience|September 2, 2025
A 3D genome compendium of breast cancer progressionTeun van den Brand, Maria Donaldson Collier, Koen D Flach, et al.
Pageof 18

Showing results (61-70 of 178) with videos related to

Sort By:
Pageof 18
Oncotarget|September 15, 2017
Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapyWillemijne A M E Schrijver, Karianne Schuurman, Annelot van Rossum, et al.
Oncotarget|April 21, 2016
mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinomaSuzan Stelloo, Joyce Sanders, Ekaterina Nevedomskaya, et al.
Genes & Development|December 28, 2019
TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer developmentLisette M Cornelissen, Anne Paulien Drenth, Eline van der Burg, et al.
JCI Insight|January 25, 2019
Frequent clonal relations between metastases and non-index prostate cancer lesionsJeroen Kneppers, Oscar Krijgsman, Monique Melis, et al.
Endocrine-Related Cancer|December 6, 2019
Androgen modulation of XBP1 is functionally driving part of the AR transcriptional programSuzan Stelloo, Simon Linder, Ekaterina Nevedomskaya, et al.
Cancer Research|August 23, 2014
Complex formation and function of estrogen receptor α in transcription requires RIP140Meritxell Rosell, Ekaterina Nevedomskaya, Suzan Stelloo, et al.
Scientific Reports|July 2, 2021
A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancerSander A L Palit, Jeroen van Dorp, Daniel Vis, et al.
Development (Cambridge, England)|February 14, 2013
The transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signalsJaya Nautiyal, Jennifer H Steel, Meritxell Rosell Mane, et al.
Nature Reviews. Urology|December 17, 2020
Genomic and phenotypic heterogeneity in prostate cancerMichael C Haffner, Wilbert Zwart, Martine P Roudier, et al.
Iscience|September 2, 2025
A 3D genome compendium of breast cancer progressionTeun van den Brand, Maria Donaldson Collier, Koen D Flach, et al.
Pageof 18